Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-24-014771
Filing Date
2024-11-21
Accepted
2024-11-21 17:14:20
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A endra_10qa.htm   iXBRL 10-Q/A 835559
2 CERTIFICATION endra_ex311.htm EX-31.1 9197
3 CERTIFICATION endra_ex312.htm EX-31.2 10847
4 CERTIFICATION endra_ex321.htm EX-32.1 4349
  Complete submission text file 0001654954-24-014771.txt   4095253

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ndra-20240930.xsd EX-101.SCH 53311
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20240930_lab.xml EX-101.LAB 285869
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20240930_cal.xml EX-101.CAL 41205
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20240930_pre.xml EX-101.PRE 233390
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20240930_def.xml EX-101.DEF 141141
62 EXTRACTED XBRL INSTANCE DOCUMENT endra_10qa_htm.xml XML 479013
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37969 | Film No.: 241485489
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)